4,259 research outputs found
Bone mineral content after renal transplantation
Forearm bone mineral content (BMC), as evaluated by photonabsorption densitometry, was measured in 28 cadaver kidney donor recipients who entered the study 8 weeks postoperatively and were followed up for 18 months. BMC decreased signifiantly (p<0.05) but marginally in placebo-treated patients (n=14) (initial BMC 1.09±0.25 g/cm; final BMC 1.05±0.24). Fourteen patients were prophylactically given 1,25(OH)2vitamin D3 in a dose which avoided hypercalcemia and hypercalciuria (sim0.25 µg/day); under 1,25(OH)2 vitamin D3 prophylaxis a significant decrease of forearm BMC was observed no longer (initial BMC 0.94±0.21 g/cm; final BMC 0.95±0.21), but the difference between placebo and 1,25(OH)2 vitamin D3 narrowly missed statistical significance (p=0.066).
It is concluded that the decrease of forearm BMC is negligible in transplant recipients with low steroid regimens. The data suggest a trend for prophylaxis with 1,25(OH)2 vitamin D3 to slightly ameliorate forearm (cortical) BMC loss
Applying Grover's algorithm to AES: quantum resource estimates
We present quantum circuits to implement an exhaustive key search for the
Advanced Encryption Standard (AES) and analyze the quantum resources required
to carry out such an attack. We consider the overall circuit size, the number
of qubits, and the circuit depth as measures for the cost of the presented
quantum algorithms. Throughout, we focus on Clifford gates as the
underlying fault-tolerant logical quantum gate set. In particular, for all
three variants of AES (key size 128, 192, and 256 bit) that are standardized in
FIPS-PUB 197, we establish precise bounds for the number of qubits and the
number of elementary logical quantum gates that are needed to implement
Grover's quantum algorithm to extract the key from a small number of AES
plaintext-ciphertext pairs.Comment: 13 pages, 3 figures, 5 tables; to appear in: Proceedings of the 7th
International Conference on Post-Quantum Cryptography (PQCrypto 2016
Entanglement Percolation in Quantum Networks
Quantum networks are composed of nodes which can send and receive quantum
states by exchanging photons. Their goal is to facilitate quantum communication
between any nodes, something which can be used to send secret messages in a
secure way, and to communicate more efficiently than in classical networks.
These goals can be achieved, for instance, via teleportation. Here we show that
the design of efficient quantum communication protocols in quantum networks
involves intriguing quantum phenomena, depending both on the way the nodes are
displayed, and the entanglement between them. These phenomena can be employed
to design protocols which overcome the exponential decrease of signals with the
number of nodes. We relate the problem of establishing maximally entangled
states between nodes to classical percolation in statistical mechanics, and
demonstrate that quantum phase transitions can be used to optimize the
operation of quantum networks.Comment: Accepted for publication in Nature Physics. This is the original
submitted versio
Detection of multipartite entanglement with two-body correlations
We show how to detect entanglement with criteria built from simple two-body
correlation terms. Since many natural Hamiltonians are sums of such correlation
terms, our ideas can be used to detect entanglement by energy measurement. Our
criteria can straightforwardly be applied for detecting different forms of
multipartite entanglement in familiar spin models in thermal equilibrium.Comment: 5 pages including 2 figures, LaTeX; for the proceedings of the DPG
spring meeting, Berlin, March 200
Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations
We have previously described how a series of trials sponsored by Pfizer of its antifungal drug, fluconazole, in cancer patients with neutropenia handicapped the control drug, amphotericin B, by flaws in design and analysis. We describe similar problems in two pivotal trials of Pfizer's new antifungal agent, voriconazole, published in a prestigious journal. In a non-inferiority trial, voriconazole was significantly inferior to liposomal amphothericin B, but the authors concluded that voriconazole was a suitable alternative. The second trial used amphothericin B deoxycholate as comparator, but handicapped the drug by not requiring pre-medication to reduce infusion-related toxicity or substitution with electrolytes and fluid to reduce nephrotoxicity, although the planned duration of treatment was 84 days. Voriconazole was given for 77 days on average, but the comparator for only 10 days, which precludes a meaningful comparison. In a random sample of 50 references to these trials, we found that the unwarranted conclusions were mostly uncritically propagated. It was particularly surprising that relevant criticism raised by the FDA related to the first trial was only quoted once, and that none of the articles noted the obvious flaws in the design of the second trial. We suggest that editors ensure that the abstract reflects fairly on the remainder of the paper, and that journals do not impose any time limit for accepting letters that point out serious weaknesses in a study that have not been noted before
Species-specific differences in the Pro-Ala rich region of cardiac myosin binding protein-C
Cardiac myosin binding protein-C (cMyBP-C) is an accessory protein found in the A-bands of vertebrate sarcomeres and mutations in the cMyBP-C gene are a leading cause of familial hypertrophic cardiomyopathy. The regulatory functions of cMyBP-C have been attributed to the N-terminus of the protein, which is composed of tandem immunoglobulin (Ig)-like domains (C0, C1, and C2), a region rich in proline and alanine residues (the Pro-Ala rich region) that links C0 and C1, and a unique sequence referred to as the MyBP-C motif, or M-domain, that links C1 and C2. Recombinant proteins that contain various combinations of the N-terminal domains of cMyBP-C can activate actomyosin interactions in the absence of Ca2+, but the specific sequences required for these effects differ between species; the Pro-Ala region has been implicated in human cMyBP-C whereas the C1 and M-domains appear important in mouse cMyBP-C. To investigate whether species-specific differences in sequence can account for the observed differences in function, we compared sequences of the Pro-Ala rich region in cMyBP-C isoforms from different species. Here we report that the number of proline and alanine residues in the Pro-Ala rich region varies significantly between different species and that the number correlates directly with mammalian body size and inversely with heart rate. Thus, systematic sequence differences in the Pro-Ala rich region of cMyBP-C may contribute to observed functional differences in human versus mouse cMyBP-C isoforms and suggest that the Pro-Ala region may be important in matching contractile speed to cardiac function across species
Non-Standard Neutrino Propagation and Pion Decay
Motivated by the findings of the OPERA experiment, we discuss the hypothesis
that neutrino propagation does not obey Einstein special relativity. Under a
minimal set of modifications of the standard model Lagrangian, we consider the
implications of non standard neutrino propagation on the description of
neutrino interactions and, specifically, on the pion decay processes. We show
that all the different dispersion relations which have been proposed so far to
explain OPERA results, imply huge departures from the standard expectations.
The decay channel becomes significantly larger than
in the standard scenario, and may even dominate over . Moreover, the spectral distribution of neutrinos produced in the decay
processes and the probability that a pion decays in flight in neutrinos show
large deviations from the standard results.Comment: 17 pages, 10 figures, version accepted in JHE
Homeomorphisms generated from overlapping affine iterated function systems
We develop the theory of fractal homeomorphisms generated from pairs of
overlapping affine iterated function systems
- …